Gene Testing Identifies Lung Cancer Patients Who Benefit From ALK-Inhibitor Drug
Links shared publicly online about this topic.
- 1,459total visits
Gene Testing Identifies Lung Cancer Patients Who Benefit From ALK-Inhibitor Drug
Results of a new study in non-small cell lung cancer showed that patients with specific oncogenic rearrangements of the anaplastic lymphoma kinase (alk) gene within the short arm of chromosome 2
View full resource at medicalnewstoday.com
Tags: Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Lymphoma, Lung, Drug, Genes
Most Recently Shared on January 14, 2010 at 11:15 am By:
Gene Testing Identifies Lung Cancer Patients Who Benefit From ALK-Inhibitor Drug http://mnt.to/3wfp
Also Shared By:
Advertisement
medical_tweets
@medical_tweets
Gene Testing Identifies Lung Cancer Patients Who Benefit From ALK-Inhibitor Drug Results of a new study in non-small .. http://bit.ly/5l0l8r
1 year ago...